Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 22;33(52):7462-8.
doi: 10.1016/j.vaccine.2015.09.095. Epub 2015 Oct 23.

Novel approaches to whole sporozoite vaccination against malaria

Else M Bijker  1 , Steffen Borrmann  2 , Stefan H Kappe  3 , Benjamin Mordmüller  4 , Brandon K Sack  5 , Shahid M Khan  6
Affiliations
Review

Novel approaches to whole sporozoite vaccination against malaria

Else M Bijker et al. Vaccine. .

Abstract

The parasitic disease malaria threatens more than 3 billion people worldwide, resulting in more than 200 million clinical cases and almost 600,000 deaths annually. Vaccines remain crucial for prevention and ultimately eradication of infectious diseases and, for malaria, whole sporozoite based immunization has been shown to be the most effective in experimental settings. In addition to immunization with radiation-attenuated sporozoites, chemoprophylaxis and sporozoites (CPS) is a highly efficient strategy to induce sterile protection in humans. Genetically attenuated parasites (GAP) have demonstrated significant protection in rodent studies, and are now being advanced into clinical testing. This review describes the existing pre-clinical and clinical data on CPS and GAP, discusses recent developments and examines how to transform these immunization approaches into vaccine candidates for clinical development.

Keywords: Chemoprophylaxis; Chloroquine; Genetic attenuation; Immunization; Liver stage; Malaria; Plasmodium; Pre-erythrocytic stages; Sporozoite; Vaccine.

PubMed Disclaimer

References

    1. Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008;9(7):725–32. - PubMed
    1. WHO. World malaria report. 2014.
    1. The malERA Consultative Group on Vaccines. A research agenda for malaria eradication: vaccines. PLoS Med. 2011;8(1):e1000398. - PMC - PubMed
    1. Hellriegel B. Immunoepidemiology—bridging the gap between immunology and epidemiology. Trends Parasitol. 2001;17(2):102–6. - PubMed
    1. Tran TM, Li S, Doumbo S, Doumtabe D, Huang CY, Dia S, et al. An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis. 2013;57(1):40–7. (an official publication of the Infectious Diseases Society of America). - PMC - PubMed